Stock GLS GLENMARK LIFE SCIENCES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Glenmark Life Sciences Limited Bombay S.E.

Equities

GLS

INE03Q201024

Market Closed - Bombay S.E.
Other stock markets
 03:30:55 18/07/2024 pm IST 		5-day change 1st Jan Change
851.8 INR -0.26% Intraday chart for Glenmark Life Sciences Limited +1.07% +29.64%
11/07 Glenmark Pharmaceuticals to Sell 7.84% Stake in Glenmark Life Sciences MT
10/07 Glenmark Pharma to Sell 7.84% Stake in Glenmark Life via Offer for Sale CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Glenmark Pharmaceuticals to Sell 7.84% Stake in Glenmark Life Sciences
MT
Granules India posts Q4 revenue fall on weak paracetamol sales, price erosion
RE
Glenmark Life Sciences Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024
CI
Glenmark Life Sciences Limited Reports Earnings Results for the Full Year Ended March 31, 2024
CI
Nirma Limited completed the acquisition of 75% stake in Glenmark Life Sciences Limited from Glenmark Pharmaceuticals Limited.
CI
Nirma Limited completed the acquisition of 0.000738% stake in Glenmark Life Sciences Limited.
CI
India's Glenmark Pharma posts loss for Q3 as remediation cost weighs
RE
India's Glenmark Life Sciences posts Q3 profit rise; strong orderbook ahead, says CEO
RE
Glenmark Life Sciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
CI
Paracetamol maker Granules India posts marginal rise in Q3 profit
RE
Glenmark Life Signs Master Supply Agreement with Japanese Drugmaker for Urinary Anti-Spasmodic API
MT
Glenmark Life Sciences Announces Another CDMO Deal
CI
India's Glenmark Pharma posts Q2 loss on exceptional legal costs
RE
Paracetamol maker Granules India's Q2 revenue rises on higher N.America demand
RE
India's Glenmark Life Sciences posts Q2 profit rise on API boost
RE
Glenmark Life Sciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
CI
Glenmark Life Sciences Limited Declares Interim Equity Dividend for the Financial Year 2023-24, Payable on or After October 23, 2023
CI
Indian paracetamol maker Valiant Laboratories lists at 16% premium
RE
Glenmark Life Sciences Limited Approves Interim Dividend for the Financial Year 2022-23
CI
Glenmark Pharmaceuticals to Divest Majority Stake in Glenmark Life Sciences for INR56.5 Billion
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GLS Stock
  4. GLS Stock
  5. News Glenmark Life Sciences Limited
  6. Highlights